Latest News about SRPT
Recent news which mentions SRPT
Sarepta Therapeutics' Therapy Becomes First To Score FDA Nod For Duchenne Muscular Dystrophy Gene Therapy
June 22, 2023
Tickers
SRPT
From Benzinga
RegenXbio's Potential Blockbuster: Analyst is Bullish On Stock Citing Potential Gains From AAV Gene Therapies Resurgence
June 20, 2023
From Benzinga
From InvestorPlace
Tickers
SRPT
From Motley Fool
Tickers
SRPT
From Motley Fool
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 24, 2023
From Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2023
May 24, 2023
From Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
From Motley Fool
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 15, 2023
From Benzinga
From Benzinga
Why Is Sarepta (SRPT) Stock Up 29% Today?
May 15, 2023
From InvestorPlace
From Benzinga
From Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Monday, May 15, 2023: TSLA, SRPT, TJX, MNDY, LTRY
May 15, 2023
From Benzinga
FDA AdComm Narrowly Supports Approval Of Sarepta's Gene Therapy For Rare Neuromuscular Disorder
May 15, 2023
Tickers
SRPT
From Benzinga
2 Supercharged Growth Stocks to Buy Right Now
May 14, 2023
From Motley Fool
FDA Staff Raises Issues For Sarepta's Duchenne Gene Therapy Data, Analyst Says Issues Known, Expects Positive Vote
May 10, 2023
Tickers
SRPT
From Benzinga
From Benzinga
From Benzinga
Tickers
SRPT
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.